DATABASE

ABCDEFGHIJKLMNOPQRSTUVWXYZ


Name Category
Antero Res Fin 7.25% Company
Anterra and Terrex Announce Mailing of Business Combination Circular and Amendment to Arrangement News
Anterra and Terrex Announce Mailing of Business Combination Circular and Amendment to Arrangement News
Anterra and Terrex Complete Business Combination News
Anterra and Terrex Complete Business Combination News
Anterra and Terrex Enter Into Business Combination, Agree to Settlement of Terrex Creditor Obligations and Anterra to Complete Financing News
Anterra and Terrex Enter Into Business Combination, Agree to Settlement of Terrex Creditor Obligations and Anterra to Complete Financing News
Anterra Completes $7 Million Financing With LandOcean News
Anterra Energy Announces 2012 Year End Reserves and Financial Results News
Anterra Energy Announces Corporate Update and First Quarter Financial Results News
Anterra Energy Announces Expected Mailing Date of Business Combination Circular and Provides Corporate and Operational Update News
Anterra Energy Announces Second Quarter Financial Results News
Anterra Energy Inc Fund
Anterra Energy Provides Operations and Financing Update News
Antevenio SA Fund
ANTH's Blisibimod Enters Phase III News
Anthea Bird Contact
Anthea Pang Contact
Anthem and WellPoint Complete Merger News
Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus News
Anthera Announces First Quarter 2013 Financial Report and Conference Call News
Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod News
Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study News
ANTHERA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report News
ANTHERA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report News
Page 682 of 1100